Corpus Intelligence IC Memo — COMMUNITY MEMORIAL HOSPITAL 2026-04-26 03:45 UTC
IC Memo — COMMUNITY MEMORIAL HOSPITAL
Investment Committee Memorandum | WI | 186 beds | Grade C | EBITDA uplift $17.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COMMUNITY MEMORIAL HOSPITAL

CCN 520103 | WAUKESHA, WI | 186 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COMMUNITY MEMORIAL HOSPITAL is a 186-bed under-performing / distressed in WAUKESHA, WI with $238.9M in net patient revenue and a -17.7% operating margin. The hospital serves a payer mix of 31.0% Medicare, 4.3% Medicaid, and 64.7% commercial.

Thesis: Undervalued. Our ML models identify $17.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.7% to -10.4% (+736bps).

Net Revenue HCRIS$238.9M
Current EBITDA COMPUTED$-42.3M
Operating Margin COMPUTED-17.7%
Occupancy HCRIS47.7%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS27.0%
Distress Probability ML48.7%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
32
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -17.7% places it below the state median. Among 32 size-comparable peers (93-372 beds), the median margin is 0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (93-372), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COMMUNITY MEMORIAL HOSPITAL (Target)WI186$238.9M-17.7%
CHILDRENS HOSPITAL OF WISCONSIWI298$795.1M5.0%
MARSHFIELD MEDICAL CENTERWI194$765.7M-13.0%
MCHS EAU CLAIRE HOSPITALWI186$676.4M-5.5%
BELLIN MEMORIAL HOSPITALWI175$652.3M13.7%
ST. VINCENT HOSPITALWI237$649.4M1.9%
ASPIRUS WAUSAU HOSPITALWI239$645.7M3.1%
AURORA BAYCARE MEDICAL CENTERWI190$558.0M17.6%
WAUKESHA MEMORIAL HOSPITALWI270$545.6M3.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $17.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.0M+210bp18mo
Cost to Collect4.5%2.5%$4.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.9M+122bp9mo
Clean Claim Rate88.0%96.0%$153K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.0M
Cost to Collect
$4.8M
Denial Rate Reduction
$4.7M
A/R Days Reduction
$2.9M
Clean Claim Rate
$153K
Total EBITDA Uplift$17.6M
Current EBITDA$-42.3M
+ RCM Uplift+$17.6M
Pro Forma EBITDA$-24.8M
Current Margin-17.7%
Pro Forma Margin-10.4%
WC Released (1x)$9.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-65.1M$-103.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-65.1M$-134.9M0.00x-100.0%
Bull Case9.0x11.0x$-58.6M$-98.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-58.6M$-124.2M0.00x-100.0%
Bear Case11.0x10.0x$-71.6M$-170.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-71.6M$-210.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 93-372 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-10.4% / P50=0.8% / P75=6.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.